Addiction Treatment Services

Addiction is a chronic disease, which causes individuals to seek “reward” from substance-use or other activities whether or not they may cause harm. Addiction treatment has been in the spotlight as payers, policymakers, and health systems struggle to address the opioid crisis and increasing substance-related mortality rates. As a result, the addiction treatment market is shifting—there is expanded coverage for residential treatment, a push towards greater integration and care coordination, and new competitors entering the market—creating new challenges and opportunities for organizations working in addiction treatment.

Latest Resources

• Research That Matters: Reduced Emergency Department Use Among Insured Individuals Receiving Extended-Release Buprenorphine In A Health System Setting
• Research That Matters: Recovery From Opioid Use Disorder (OUD) After Monthly Long-Acting Buprenorphine Treatment: 12-Month Longitudinal Outcomes From RECOVER, An Observational Study
• Research That Matters: Patient-Reported Outcomes Of Treatment Of Opioid Dependence With Weekly & Monthly Subcutaneous Depot Vs. Daily Sublingual Buprenorphine, A Randomized Clinical Trial
• Data As A Strategic Asset: A Conversation On Organizational Data Leadership With Heidi Milch, LMSW, Executive Director Of CCNY
• CMS Adds Medicare Options to Help People Manage Substance Use Disorder, Heart Failure, and Other Common Chronic Conditions
• Houston Opens 222-Bed Homeless Resource Center Operated By The Harris Center Under $39 Million Contract
• New Jersey Restores $16.45 Million In Funding For Five Crisis Centers
• Building The Missing Model
• Community Action Treatment (CAT) Team By Bridgeway Center, Inc.: An OPEN MINDS Program Profile
• Configuring Your EHR To Optimize Quality Data: Building the Foundation for Better Insights
• Buprenorphine Availability At Pharmacies Increased In Both Rural & Urban Counties
• Chaptered Maryland Senate Bill 453 Mental Health: Assisted Outpatient Treatment Programs
• Buprenorphine Dispensed By Pharmacies & Administered In Emergency Departments In Urban & Rural Areas — United States, 2019 – 2025
• Cannabis Use Disorder Increased Among U.S. Adults
• Arizona Did Not Ensure That Selected Medicaid Managed Care Organizations Complied With Mental Health & Substance Use Disorder Parity Requirements Related To Prior Authorization

See All

States With SUD IMD Waivers Report Higher Utilization Of Inpatient & Residential SUD Treatment

Six states that implemented Section 1115 waivers covering Medicaid payments to Institutions for Mental Disease (IMDs) for substance use disorder (SUD) treatment reported that higher utilization of inpatient and residential SUD treatment, with some evidence of expanded treatment capacity. Using IMDs as a treatment setting expanded access to services and medications for opioid use disorder (OUD). The six states are California, Indiana, Massachusetts, New Hampshire, Utah, and Washington. Historically, Medicaid has not reimbursed for services… Read

• Nebraska Substance Use Disorder (SUD) Program Section 1115(a) Demonstration Amendment
• Insurers, Medical Societies & Provider Organizations Sign HHS Pledge To Advance National Behavioral Health Quality & Best Practices
• 16% Of Americans With A Substance Use Disorder Get Treatment
• A Quarter Of Adults Entering SUD Treatment Screen Positive For Psychosis
• Clinical Results Need Financial Innovation

To sign-up for bi-weekly Mental Health alerts, you must be signed in to your account.